Lanthanide-doped upconversion nanoparticles (UCNPs) have emerged as promising platforms for bioimaging and theranostics owing to their unique ability to convert near-infrared (NIR) excitation into visible emission. Controlling their emission behavior is critical for both mechanistic understanding and biomedical translation. In this work, we synthesized NaYF4: Yb3+, Er3+, Tm3+ UCNPs via a hydrothermal route and systematically investigated their power-dependent luminescence. Log–log slope analysis clarified photon participation in different emission bands, revealed competition between Yb3+→Er3+ and Yb3+→Tm3+ pathways, and identified saturation effects at higher excitation power. Based on these insights, the nanoparticles were functionalized with silica–TPGS to improve colloidal stability, dispersibility, and biocompatibility. Preliminary biological evaluation with MCF-7 breast cancer cells demonstrated efficient uptake, bright intracellular luminescence, and dose-dependent cytotoxicity (GI₅₀ = 0.26 ± 0.02 ppm). These findings highlight excitation-power control as a powerful strategy for tailoring UCNP emission properties, laying the foundation for advanced applications in ratiometric sensing, multicolor imaging, and cancer theranostics.
Huong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: